Date published: 2025-11-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

Dbl Inhibitors

Dbl inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of Dbl proteins, a family of guanine nucleotide exchange factors (GEFs) that are crucial in the regulation of small GTPases, particularly those in the Rho family. The Dbl family proteins act as molecular switches, facilitating the exchange of GDP for GTP on Rho GTPases, thereby activating them. These activated Rho GTPases, such as RhoA, Rac1, and Cdc42, play pivotal roles in various cellular processes, including cytoskeletal organization, cell migration, cell division, and gene expression. The Dbl homology (DH) domain is the signature motif in these proteins, responsible for their GEF activity, while the adjacent pleckstrin homology (PH) domain often helps in membrane localization and interaction with other signaling molecules. Inhibitors of Dbl proteins typically function by binding to the DH domain or other critical regions that are essential for their interaction with Rho GTPases. By inhibiting the activity of Dbl proteins, these compounds can prevent the activation of Rho GTPases, thereby disrupting downstream signaling pathways that rely on these small GTPases. This inhibition can lead to a range of cellular effects, such as alterations in cytoskeletal dynamics, reduced cell motility, and impaired cell cycle progression. Since Rho GTPases are involved in regulating the actin cytoskeleton, Dbl inhibitors may also impact processes like cell shape, adhesion, and intracellular trafficking. Additionally, Dbl inhibitors could affect the broader network of signaling pathways connected to Rho GTPases, influencing cellular responses to external stimuli and overall cellular homeostasis. Understanding the effects of Dbl inhibition provides valuable insights into the molecular mechanisms of cell signaling and the regulation of cytoskeletal architecture, highlighting the critical roles these proteins play in maintaining cellular function and integrity. This knowledge is fundamental for exploring how disruptions in Dbl-mediated pathways can impact various cellular behaviors and physiological processes.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

Y-27632 is a ROCK inhibitor, which indirectly affects Dbl-regulated pathways by inhibiting downstream Rho-associated kinase, altering cytoskeletal dynamics and cell motility.

NSC 23766

733767-34-5sc-204823
sc-204823A
10 mg
50 mg
$148.00
$597.00
75
(4)

NSC23766 specifically inhibits Rac1, a GTPase regulated by certain Dbl family members, disrupting Rac1-dependent signaling and cellular functions.

CCG-1423

285986-88-1sc-205241
sc-205241A
1 mg
5 mg
$30.00
$90.00
8
(1)

CCG-1423 targets the RhoA/serum response factor (SRF) pathway, potentially affecting downstream effects of Dbl-mediated Rho GTPase activation.

ML 141

71203-35-5sc-362768
sc-362768A
5 mg
25 mg
$134.00
$502.00
7
(1)

ML141 is a selective inhibitor of Cdc42, a Rho GTPase that some Dbl family GEFs activate, thereby influencing actin organization and cell morphology.

Rhosin

1173671-63-0sc-507401
25 mg
$555.00
(0)

Rhosin inhibits RhoA GTPase, thereby indirectly affecting the cellular functions regulated by Dbl family GEFs through RhoA modulation.

ITX 3

347323-96-0sc-295214
sc-295214A
10 mg
50 mg
$145.00
$615.00
(0)

ITX3 inhibits Trio, a Dbl family GEF, thus indirectly impacting its role in the activation of Rho GTPases like Rac1 and RhoG.

EHT 1864

754240-09-0sc-361175
sc-361175A
10 mg
50 mg
$209.00
$872.00
12
(2)

EHT 1864 is a potent Rac GTPase inhibitor, impacting pathways regulated by Dbl family GEFs that activate Rac, thereby influencing cell adhesion and migration.

Tozasertib

639089-54-6sc-358750
sc-358750A
25 mg
50 mg
$61.00
$85.00
4
(1)

Tozasertib, a kinase inhibitor, may indirectly impact Dbl family GEF function through inhibition of kinase-dependent signaling pathways.

GSK 269962

850664-21-0sc-363279
sc-363279A
10 mg
50 mg
$300.00
$1000.00
1
(0)

GSK269962A inhibits ROCK1/2, kinases influenced by Rho GTPases, which are regulated by Dbl family GEFs, affecting vascular tone and leukocyte recruitment.

Securinine

5610-40-2sc-220097
sc-220097A
50 mg
100 mg
$265.00
$410.00
3
(1)

Securinine has been shown to modulate GEF activity, potentially impacting Dbl-related signaling pathways indirectly through its GEF modulatory effects.